Exploratory Study: COVID-19 and Pregnancy
Exploratory Study: COVID-19 and Pregnancy
The SARS-CoV-2 infection may behave differently in pregnant and postpartum women in the short
 and long term. Several risk factors or medication use can interfere on disease' evolution and
 vertical transmission. Thus, due the current pandemic and the scarcity of scientific studies
 involving pregnant women with covid-19 or positive serology, combined with the need to
 elucidate the behavior of this viral infection in pregnant women in our population, this
 study aims to evaluate the clinical and laboratory evolution, transplacental passage,
 gestational and neonatal outcomes in pregnancies with positive SARS-CoV-2.
Inclusion Criteria:

 -  Pregnant women with clinical symptoms or positive serology for SARS-CoV-2 hospitalized
 or in delivery time;

 -  Asymptomatic pregnant women for SARS-CoV-2 during pregnancy and hospitalized for
 delivery at HU-USP.

 -  Pregnant women diagnosed with SARS-CoV-2 prior to delivery and who, after the
 quarantine period, followed prenatal care and delivered at the HU-USP or HCFMUSP.

 Exclusion Criteria:

 -  Non-confirmation of maternal SARS-CoV-2 infection in pregnant women hospitalized or in
 delivery time.

 -  Withdrawal of pregnant woman to continue in the study.